Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

Clinical trial NCT00948753 · COMPLETED

Trial details

NCT number: NCT00948753
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft-versus-host Disease Hematopoietic Stem Cell Transplantation

Start date: 2009-06-01
Primary completion: 2011-04-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.